Last reviewed · How we verify

NCT03939910

Effect of Preemptive Pudendal Nerve Block Using Bupivacaine Versus Ropivacaine on Post-operative Pain After Posterior Vaginal Repair.

Status unknown NA Last updated 7 May 2019
What this trial tests

NA trial testing Pudendal Nerve Block needle in pre-packaged kits that include both the trumpet and the needle. The needle will limits its depth of penetration to 5 mm beyond the trumpet. in Post-operative Pain After Posterior Vaginal Repair in 72 participants. Status unknown.

Timeline
1 June 2019
Primary endpoint
30 December 2020
30 June 2021

Quick facts

Lead sponsorMunazzah Rafique
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment72
Start date1 June 2019
Primary completion30 December 2020
Estimated completion30 June 2021

Drugs / interventions tested

Conditions studied

Sponsor

Munazzah Rafique

Who can join

Adults 20 to 80, female only, with Post-operative Pain After Posterior Vaginal Repair. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the efficacy of preemptive pudendal nerve blockade on postoperative pain, after posterior vaginal repair, below the level of ischial spine, excluding uterine suspension procedures that are higher than the coverage of the block. Primary outcome: The primary outcome measures of the study visual analogue pain scores and postoperative analgesic consumption.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03939910.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing